Clinical and immunologic features in severe and moderate Coronavirus Disease 2019

Overview of attention for article published in Journal of Clinical Investigation, April 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#4 of 17,328)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 81 news outlets
blogs: 4 blogs
twitter: 3107 X users
patent: 11 patents

facebook: 4 Facebook pages
wikipedia: 2 Wikipedia pages
video: 2 YouTube creators

Citations

dimensions_citation: 4032 Dimensions

Readers on

mendeley: 3608 Mendeley

Summary News Blogs X Patents Facebook Wikipedia YouTube Dimensions citations

So far, Altmetric has seen 114 news stories from 81 outlets.

A complete SARS-CoV-2 and COVID-19 overview, Half 2: host extracellular to systemic results of SARS-CoV-2 an infection – European Journal of Human Genetics

PressNewsAgency, 08 Nov 2023

Rydland HT, Friedman J, Stringhini S, Hyperlink BG, Eikemo TA. The radically unequal distribution of Covid-19 vaccinations: a…

Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection

Health Reporter, 07 Jun 2023

What Your COVID Immunity May Be Like With A 4th Shot

Yahoo!, 07 Apr 2022

A fourth COVID-19 shot has been authorized for people over the age of 50 along with those under 50 who are immunocompromised.

Tiziana Life Sciences announces collaboration with Parexel Biotech to conduct phase 1b/2 clinical trial in patients with Crohn’s Disease

Biz Wire Express, 11 Nov 2020

First Ever Study with take-home capsules of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody Potential to be a safer and…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 110 additional news stories.